<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="interaction" /><meta name="keywords" content="" /><title>Corticosteroids: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../383/theme.css" /><link type="text/css" rel="stylesheet" href="204/style.css" /><link type="image/x-icon" rel="shortcut icon" href="../../favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="bnf_int484-corticosteroids.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.8/jquery.min.js"></script><script type="text/javascript" src="../../383/scripts.js"></script><style type="text/css">
          .contentsbox { position: fixed; z-index:1001; }
          .contentsbox_wrap { overflow: hidden; width: 20px; height: 130px; position: absolute; left: 0; top: 0; }
        </style><!--[if IE 8]>
          <style type="text/css">
          #p1 {
          float: left;
          padding-bottom: 15em;
          }
          </style>
          <![endif]--><!--[if lte IE 8]>
          <style type="text/css">
          #start-search input {
          height: 28px;
          padding-top: 8px;
          }
          @media screen {
          #pV {
          display: block !important;
          }
          }
          </style>
          <![endif]--><!--[if IE 7]>
          <style type="text/css">
          #start-search input {
          position: absolute !important;
          left: 0;
          top: 0;
          }
          .as-shadow {
          margin-left: -4px !important;
          color: silver;
          }
          </style>
          <![endif]--><!--[if lte IE 7]>
          <style type="text/css">
          .menu {
          height: 1%;
          }
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }

          #account-info ul li a {
          width: 12em;
          }
          #opts ul li span {
          width: 12em;
          }
          div.as-select ul li ul li span {
          width: 40em;
          }
          div.menu ul li ul li {
          float: left !important;
          }
          #pQ fieldset, #qd, #input-box, #pub-list, #start-search, #end-search {
          display: inline;
          float: left;
          height: 100%;
          padding: 0;
          margin: 0;
          position: relative;
          }
          #hM a, #hM a img {
          border: none;
          display: inline-block;
          float: left;
          }
          #qd input {
          float: left;
          display: inline-block !important;
          }
          #start-search input {
          height: 28px;
          padding-top: 8px !important;
          }
          #end-search, #end-search input {
          height: 36px !important;
          }
          #hM, #content, #searchForm, #purple-menu {
          width: expression(document.body.clientWidth > 63 * parseInt(document.body.currentStyle.fontSize) ? '63em': 'auto');
          margin: 0 auto;
          }
          #pQ {
          z-index: 1;
          }
          </style>
          <![endif]--><!--[if lte IE 6]>
          <style type="text/css">
          body {
          height: 100%;
          }
          div.menu ul li a, div.menu ul li span {
          display: inline-block;
          }
          div.menu ul li ul li {
          clear: both;
          }
          div.as-select ul li span {
          height: 20px;
          padding-top: 16px;
          padding-left: 1em;
          padding-bottom: 0;
          padding-left: 1em;
          margin: 4px 0;
          border-right: 1px solid #888;
          background-image: url("images/dropdown_img.png");
          background-repeat: repeat-x;
          overflow-x: hidden;
          }
          div.as-select ul li ul li span {
          font: bold 10px Verdana !important;
          padding: 4px 1em !important;
          color: #2D2D2D;
          background: white;
          text-decoration: none !important;
          white-space: nowrap;
          border: none !important;
          float: left;
          }
          div.menu span.hover {
          background: #8F1F8D;
          color: white;
          }
          </style>
          <![endif]--></head><body><!--[if lte IE 6]>
          <script type="text/javascript">
          jQuery(document).ready(function($) {
          $('a.mclogo').html('<img src="images/mc_logo.gif" class="logo" />');
          });
          </script>
          <![endif]--><?highlighter off?><div id="hC"><div id="vH"><div id="pU"><a class="mclogo" href="http://www.medicinescomplete.com/about/"><img class="logo" src="../../images/mc_logo.png" alt="MedicinesComplete" /></a><div id="hM"><div id="vM" class="menu"><ul><li><a href="http://www.medicinescomplete.com/mc/index.htm">Home</a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm">Help</a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=bnf_int484-corticosteroids.htm">Feedback</a></li><li id="account-info"><a href="http://www.medicinescomplete.com/mc/account.htm">BNF.org Free Access</a><ul><li><a href="http://www.medicinescomplete.com/mc/account.htm">My Account</a></li><li><a href="http://www.medicinescomplete.com/mc/subscribe.htm">Subscribe</a></li><li><a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li><a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul></li></ul></div><a id="pD" accesskey="s" rel="bookmark" href="bnf_int484-corticosteroids.htm#pB" title="Skip Navigation">Skip Navigation</a></div></div><div id="pA"><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 12 Mar 2013 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="search-in">Publication</label><label for="q">Search for</label><div id="qd"><div id="start-search"><div class="as-select menu" id="pub-list"><ul><li><span>British National Formulary</span><ul></ul></li></ul></div><div id="input-box"><input type="text" id="q" name="q" accesskey="4" /></div></div><div id="end-search"><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div></div></div><div id="pH"><div id="pN"><div id="pT"><!--[if lte IE 7]>
             
            <![endif]--><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF March 2013</a> &gt; <a href="PHP8848-interactions.htm">Appendix 1 Interactions</a> &gt; <a href="PHP8852-list-of-drug-interactions.htm">List of drug interactions</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="bnf_int978-contraceptives-oral.htm" title="Previous: Contraceptives, oral">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="bnf_int1193-prednisone.htm" title="Next: Prednisone">Next page</a> ►</div></div></div></div><div id="content"><div id="p1"><div id="pB"><?highlighter on?><h1>Corticosteroids</h1><?highlighter off?><?highlighter on?><div id="pC" class="jN"><p><strong>Corticosteroids</strong> has the following interaction information:</p><div class="cG"><p><strong>Note:</strong> Interactions do not generally apply to corticosteroids used for topical action (including inhalation) unless specified</p></div><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int2-ace-inhibitors.htm">ACE Inhibitors</a></td><td><p><span></span> <span>corticosteroids</span> <span>antagonise hypotensive effect of</span> <span>ACE inhibitors</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int551-acetazolamide.htm">Acetazolamide</a></td><td><p><span>increased risk of hypokalaemia when </span><span>corticosteroids</span> <span>given with</span> <span>acetazolamide</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int15-adrenergic-neurone-blockers.htm">Adrenergic Neurone Blockers</a></td><td><p><span></span> <span>corticosteroids</span> <span>antagonise hypotensive effect of</span> <span>adrenergic neurone blockers</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int21-aldesleukin.htm">Aldesleukin</a></td><td class="cAI"><p><span>avoidance of </span><span>corticosteroids</span> <span>advised by manufacturer of</span> <span>aldesleukin</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int26-alpha-blockers.htm">Alpha-blockers</a></td><td><p><span></span> <span>corticosteroids</span> <span>antagonise hypotensive effect of</span> <span>alpha-blockers</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int290-amphotericin.htm">Amphotericin</a></td><td class="cAI"><p><span>increased risk of hypokalaemia when </span><span>corticosteroids</span> <span>given with</span> <span>amphotericin</span><span>—avoid concomitant use unless <span>corticosteroids</span> needed to control reactions</span></p></td><td><div class="cG"><p><strong>Note:</strong> Close monitoring required with concomitant administration of nephrotoxic drugs or cytotoxics</p></div></td></tr><tr><td><a href="bnf_int107-angiotensin-ii-receptor-antagonists.htm">Angiotensin-II Receptor Antagonists</a></td><td><p><span></span> <span>corticosteroids</span> <span>antagonise hypotensive effect of</span> <span>angiotensin-II receptor antagonists</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int264-antidiabetics.htm">Antidiabetics</a></td><td><p><span></span> <span>corticosteroids</span> <span>antagonise hypoglycaemic effect of</span> <span>antidiabetics</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int361-aspirin.htm">Aspirin</a></td><td><p><span>increased risk of gastro-intestinal bleeding and ulceration when </span><span>corticosteroids</span> <span>given with</span> <span>aspirin</span><span>, also <span>corticosteroids</span> reduce plasma concentration of salicylate</span></p></td><td></td></tr><tr><td><a href="bnf_int440-beta-blockers.htm">Beta-blockers</a></td><td><p><span></span> <span>corticosteroids</span> <span>antagonise hypotensive effect of</span> <span>beta-blockers</span> <span></span></p></td><td><div class="cG"><p><strong>Note:</strong> Since systemic absorption may follow topical application of beta-blockers to the eye the possibility of interactions, in particular, with drugs such as verapamil should be borne in mind</p></div></td></tr><tr><td><a href="bnf_int465-calcium-salts.htm">Calcium Salts</a></td><td><p><span></span> <span>corticosteroids</span> <span>reduce absorption of</span> <span>calcium salts</span> <span></span></p></td><td><div class="cG"><p><strong>Note:</strong> <em>see also</em> Antacids</p></div></td></tr><tr><td><a href="bnf_int466-calcium-channel-blockers.htm">Calcium-channel Blockers</a></td><td><p><span></span> <span>corticosteroids</span> <span>antagonise hypotensive effect of</span> <span>calcium-channel blockers</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int277-carbamazepine.htm">Carbamazepine</a></td><td class="cAI"><p><span>metabolism of </span><span>corticosteroids</span> <span>accelerated by</span> <span>carbamazepine</span> <span>(reduced effect)</span></p></td><td></td></tr><tr><td><a href="bnf_int478-cardiac-glycosides.htm">Cardiac Glycosides</a></td><td><p><span>increased risk of hypokalaemia when </span><span>corticosteroids</span> <span>given with</span> <span>cardiac glycosides</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int482-clonidine.htm">Clonidine</a></td><td><p><span></span> <span>corticosteroids</span> <span>antagonise hypotensive effect of</span> <span>clonidine</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int220-coumarins.htm">Coumarins</a></td><td class="cAI"><p><span></span> <span>corticosteroids</span> <span>may enhance or reduce anticoagulant effect of</span> <span>coumarins</span> <span>(high-dose <span>corticosteroids</span> enhance anticoagulant effect)</span></p></td><td><div class="cG"><p><strong>Note:</strong> Change in patient's clinical condition, particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing. Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may also affect anticoagulant control</p></div></td></tr><tr><td><a href="bnf_int522-diazoxide.htm">Diazoxide</a></td><td><p><span></span> <span>corticosteroids</span> <span>antagonise hypotensive effect of</span> <span>diazoxide</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int524-diuretics.htm">Diuretics</a></td><td><p><span></span> <span>corticosteroids</span> <span>antagonise diuretic effect of</span> <span>diuretics</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int539-diuretics-loop.htm">Diuretics, Loop</a></td><td><p><span>increased risk of hypokalaemia when </span><span>corticosteroids</span> <span>given with</span> <span>loop diuretics</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int525-diuretics-thiazide-and-related.htm">Diuretics, Thiazide and related</a></td><td><p><span>increased risk of hypokalaemia when </span><span>corticosteroids</span> <span>given with</span> <span>thiazides and related diuretics</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int169-erythromycin.htm">Erythromycin</a></td><td><p><span>metabolism of </span><span>corticosteroids</span> <span>possibly inhibited by</span> <span>erythromycin</span> <span></span></p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not apply to small amounts of erythromycin used topically</p></div></td></tr><tr><td><a href="bnf_int1180-histamine.htm">Histamine</a></td><td><p><span>avoidance of </span><span>corticosteroids</span> <span>advised by manufacturer of</span> <span>histamine</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int763-hydralazine.htm">Hydralazine</a></td><td><p><span></span> <span>corticosteroids</span> <span>antagonise hypotensive effect of</span> <span>hydralazine</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int165-isoniazid.htm">Isoniazid</a></td><td><p><span></span> <span>corticosteroids</span> <span>possibly reduce plasma concentration of</span> <span>isoniazid</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int302-itraconazole.htm">Itraconazole</a></td><td><p><span>metabolism of </span><span>corticosteroids</span> <span>possibly inhibited by</span> <span>itraconazole</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int298-ketoconazole.htm">Ketoconazole</a></td><td><p><span>metabolism of </span><span>corticosteroids</span> <span>possibly inhibited by</span> <span>ketoconazole</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int611-methyldopa.htm">Methyldopa</a></td><td><p><span></span> <span>corticosteroids</span> <span>antagonise hypotensive effect of</span> <span>methyldopa</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int1173-mifamurtide.htm">Mifamurtide</a></td><td><p><span>avoidance of </span><span>corticosteroids</span> <span>advised by manufacturer of</span> <span>mifamurtide</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int614-mifepristone.htm">Mifepristone</a></td><td><p><span>effect of </span><span>corticosteroids</span> <span>(including <em>inhaled</em><span>corticosteroids</span>) may be reduced for 3–4 days after</span> <span>mifepristone</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int764-minoxidil.htm">Minoxidil</a></td><td><p><span></span> <span>corticosteroids</span> <span>antagonise hypotensive effect of</span> <span>minoxidil</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int615-moxonidine.htm">Moxonidine</a></td><td><p><span></span> <span>corticosteroids</span> <span>antagonise hypotensive effect of</span> <span>moxonidine</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int60-nsaids.htm">NSAIDs</a></td><td><p><span>increased risk of gastro-intestinal bleeding and ulceration when </span><span>corticosteroids</span> <span>given with</span> <span>NSAIDs</span> <span></span></p></td><td><div class="cG"><p><strong>Note:</strong> <em>See also </em>Aspirin. Interactions do not generally apply to topical NSAIDs
</p></div></td></tr><tr><td><a href="bnf_int631-nitrates.htm">Nitrates</a></td><td><p><span></span> <span>corticosteroids</span> <span>antagonise hypotensive effect of</span> <span>nitrates</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int636-oestrogens.htm">Oestrogens</a></td><td><p><span>plasma concentration of </span><span>corticosteroids</span> <span>increased by oral contraceptives containing</span> <span>oestrogens</span> <span></span></p></td><td><div class="cG"><p><strong>Note:</strong> Interactions of combined oral contraceptives may also apply to combined contraceptive patches and vaginal rings, see <a title="COCs interactions (target-block)" href="PHP4869-combined-hormonal-contraceptives.htm#PHP4875">section 7.3.1</a></p></div></td></tr><tr><td><a href="bnf_int625-pancuronium.htm">Pancuronium</a></td><td><p><span></span> <span>corticosteroids</span> <span>possibly antagonise effects of</span> <span>pancuronium</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int223-phenindione.htm">Phenindione</a></td><td><p><span></span> <span>corticosteroids</span> <span>may enhance or reduce anticoagulant effect of</span> <span>phenindione</span> <span></span></p></td><td><div class="cG"><p><strong>Note:</strong> Change in patient's clinical condition particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing. Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may also affect anticoagulant control  </p></div></td></tr><tr><td><a href="bnf_int437-phenobarbital.htm">Phenobarbital</a></td><td class="cAI"><p><span>metabolism of </span><span>corticosteroids</span> <span>accelerated by</span> <span>phenobarbital</span> <span>(reduced effect)</span></p></td><td></td></tr><tr><td><a href="bnf_int284-phenytoin.htm">Phenytoin</a></td><td class="cAI"><p><span>metabolism of </span><span>corticosteroids</span> <span>accelerated by</span> <span>phenytoin</span> <span>(reduced effect)</span></p></td><td></td></tr><tr><td><a href="bnf_int199-rifamycins.htm">Rifamycins</a></td><td class="cAI"><p><span>metabolism of </span><span>corticosteroids</span> <span>accelerated by</span> <span>rifamycins</span> <span>(reduced effect)</span></p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not apply to rifaximin</p></div></td></tr><tr><td><a href="bnf_int400-ritonavir.htm">Ritonavir</a></td><td><p><span>plasma concentration of </span><span>corticosteroids</span> <span>possibly increased by</span> <span>ritonavir</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int1034-sodium-benzoate.htm">Sodium Benzoate</a></td><td><p><span></span> <span>corticosteroids</span> <span>possibly reduce effects of</span> <span>sodium benzoate</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int765-sodium-nitroprusside.htm">Sodium Nitroprusside</a></td><td><p><span></span> <span>corticosteroids</span> <span>antagonise hypotensive effect of</span> <span>sodium nitroprusside</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int1033-sodium-phenylbutyrate.htm">Sodium Phenylbutyrate</a></td><td><p><span></span> <span>corticosteroids</span> <span>possibly reduce effects of</span> <span>sodium phenylbutyrate</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int848-somatropin.htm">Somatropin</a></td><td><p><span></span> <span>corticosteroids</span> <span>may inhibit growth-promoting effect of</span> <span>somatropin</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int720-sympathomimetics-beta-2.htm">Sympathomimetics, Beta<sub>2</sub></a></td><td><p><span>increased risk of hypokalaemia when </span><span>corticosteroids</span> <span>given with high doses of</span> <span>beta<sub>2</sub> sympathomimetics</span><span>—see Hypokalaemia, <a title="CSM hypokalaemia (target-block)" href="PHP1734-selective-beta-2-agonists.htm#PHP1741">section 3.1.1.1</a></span></p></td><td></td></tr><tr><td><a href="bnf_int734-theophylline.htm">Theophylline</a></td><td><p><span>increased risk of hypokalaemia when </span><span>corticosteroids</span> <span>given with</span> <span>theophylline</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int757-vaccines.htm">Vaccines</a></td><td class="cAI"><p><span>high doses of </span><span>corticosteroids</span> <span>impair immune response to</span> <span>vaccines</span><span>, avoid concomitant use with live <span>vaccines</span> (see under Active immunity, <a title="target-block: contra-indications" href="PHP8210-active-immunity.htm#PHP8219">section 14.1</a>)</span></p></td><td><div class="cG"><p><strong>Note:</strong> For a general warning on live vaccines and high doses of corticosteroids or other immunosuppressive drugs, see <a title="target-block: contra-indications" href="PHP8210-active-immunity.htm#PHP8219">section 14.1</a>; for advice on live vaccines and immunoglobulins, see under Normal Immunoglobulin, <a title="Normal immunoglobulin notes (target-block)" href="PHP8431-normal-immunoglobulin.htm#PHP8432">section 14.5.1</a></p></div></td></tr><tr><td><a href="bnf_int626-vecuronium.htm">Vecuronium</a></td><td><p><span></span> <span>corticosteroids</span> <span>possibly antagonise effects of</span> <span>vecuronium</span> <span></span></p></td><td></td></tr></tbody></table><p><strong>Prednisone</strong> belongs to <strong>Corticosteroids</strong> but has no specific interaction information.</p><p><strong>Ciclesonide</strong> belongs to <strong>Corticosteroids</strong> and has the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int298-ketoconazole.htm">Ketoconazole</a></td><td><p><span>plasma concentration of active metabolite of </span><span>ciclesonide</span> <span>increased by</span> <span>ketoconazole</span> <span></span></p></td><td></td></tr></tbody></table><p><strong>Mometasone</strong> belongs to <strong>Corticosteroids</strong> and has the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int298-ketoconazole.htm">Ketoconazole</a></td><td><p><span>plasma concentration of <em>inhaled</em></span> <span>mometasone</span> <span>increased by</span> <span>ketoconazole</span> <span></span></p></td><td></td></tr></tbody></table><p><strong>Beclometasone</strong> belongs to <strong>Corticosteroids</strong> but has no specific interaction information.</p><p><strong>Betamethasone</strong> belongs to <strong>Corticosteroids</strong> but has no specific interaction information.</p><p><strong>Budesonide</strong> belongs to <strong>Corticosteroids</strong> and has the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int302-itraconazole.htm">Itraconazole</a></td><td><p><span>plasma concentration of <em>inhaled</em></span> <span>budesonide</span> <span>increased by</span> <span>itraconazole</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int298-ketoconazole.htm">Ketoconazole</a></td><td><p><span>plasma concentration of <em>inhaled</em> and <em>oral</em></span> <span>budesonide</span> <span>increased by</span> <span>ketoconazole</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int400-ritonavir.htm">Ritonavir</a></td><td><p><span>plasma concentration of </span><span>budesonide</span> <span>(including <em>inhaled</em>, <em>intranasal</em>, and <em>rectal</em><span>budesonide</span>) possibly increased by</span> <span>ritonavir</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int1216-telaprevir.htm">Telaprevir</a></td><td><p><span>plasma concentration of <em>inhaled</em> and <em>intranasal</em></span> <span>budesonide</span> <span>possibly increased by</span> <span>telaprevir</span> <span></span></p></td><td></td></tr></tbody></table><p><strong>Deflazacort</strong> belongs to <strong>Corticosteroids</strong> and has the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int110-antacids.htm">Antacids</a></td><td><p><span>absorption of </span><span>deflazacort</span> <span>reduced by</span> <span>antacids</span> <span></span></p></td><td><div class="cG"><p><strong>Note:</strong> Antacids should preferably not be taken at the same time as other drugs since they may impair absorption</p></div></td></tr></tbody></table><p><strong>Dexamethasone</strong> belongs to <strong>Corticosteroids</strong> and has the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int1010-aprepitant.htm">Aprepitant</a></td><td><p><span>metabolism of </span><span>dexamethasone</span> <span>inhibited by</span> <span>aprepitant</span> <span>(reduce dose of <span>dexamethasone</span>)</span></p></td><td></td></tr><tr><td><a href="bnf_int1235-axitinib.htm">Axitinib</a></td><td><p><span></span> <span>dexamethasone</span> <span>possibly decreases plasma concentration of</span> <span>axitinib</span> <span>(increase dose of <span>axitinib</span>—consult <span>axitinib</span> product literature)</span></p></td><td></td></tr><tr><td><a href="bnf_int947-caspofungin.htm">Caspofungin</a></td><td><p><span></span> <span>dexamethasone</span> <span>possibly reduces plasma concentration of</span> <span>caspofungin</span><span>—consider increasing dose of <span>caspofungin</span></span></p></td><td></td></tr><tr><td><a href="bnf_int708-ephedrine.htm">Ephedrine</a></td><td><p><span>metabolism of </span><span>dexamethasone</span> <span>accelerated by</span> <span>ephedrine</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int398-indinavir.htm">Indinavir</a></td><td><p><span></span> <span>dexamethasone</span> <span>possibly reduces plasma concentration of</span> <span>indinavir</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int922-lopinavir.htm">Lopinavir</a></td><td><p><span></span> <span>dexamethasone</span> <span>possibly reduces plasma concentration of</span> <span>lopinavir</span> <span></span></p></td><td><div class="cG"><p><strong>Note:</strong> In combination with ritonavir as <em>Kaletra</em>® (ritonavir is present to inhibit lopinavir metabolism and increase plasma-lopinavir concentration)—see also Ritonavir</p></div></td></tr><tr><td><a href="bnf_int1225-rilpivirine.htm">Rilpivirine</a></td><td class="cAI"><p><span>avoidance of </span><span>dexamethasone</span> <span>(except when given as a single dose) advised by manufacturer of</span> <span>rilpivirine</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int400-ritonavir.htm">Ritonavir</a></td><td><p><span>plasma concentration of </span><span>dexamethasone</span> <span>possibly increased by</span> <span>ritonavir</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int791-saquinavir.htm">Saquinavir</a></td><td><p><span></span> <span>dexamethasone</span> <span>possibly reduces plasma concentration of</span> <span>saquinavir</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int1216-telaprevir.htm">Telaprevir</a></td><td><p><span></span> <span>dexamethasone</span> <span>possibly reduces plasma concentration of</span> <span>telaprevir</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int1203-ticagrelor.htm">Ticagrelor</a></td><td><p><span></span> <span>dexamethasone</span> <span>possibly reduces plasma concentration of</span> <span>ticagrelor</span> <span></span></p></td><td></td></tr></tbody></table><p><strong>Fludrocortisone</strong> belongs to <strong>Corticosteroids</strong> but has no specific interaction information.</p><p><strong>Flunisolide</strong> belongs to <strong>Corticosteroids</strong> but has no specific interaction information.</p><p><strong>Fluticasone</strong> belongs to <strong>Corticosteroids</strong> and has the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int302-itraconazole.htm">Itraconazole</a></td><td><p><span>plasma concentration of <em>inhaled</em></span> <span>fluticasone</span> <span>increased by</span> <span>itraconazole</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int298-ketoconazole.htm">Ketoconazole</a></td><td><p><span>plasma concentration of <em>inhaled</em></span> <span>fluticasone</span> <span>increased by</span> <span>ketoconazole</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int400-ritonavir.htm">Ritonavir</a></td><td class="cAI"><p><span>plasma concentration of <em>inhaled</em> and <em>intranasal</em></span> <span>fluticasone</span> <span>increased by</span> <span>ritonavir</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int1216-telaprevir.htm">Telaprevir</a></td><td><p><span>plasma concentration of <em>inhaled</em> and <em>intranasal</em></span> <span>fluticasone</span> <span>possibly increased by</span> <span>telaprevir</span> <span></span></p></td><td></td></tr></tbody></table><p><strong>Hydrocortisone</strong> belongs to <strong>Corticosteroids</strong> but has no specific interaction information.</p><p><strong>Methylprednisolone</strong> belongs to <strong>Corticosteroids</strong> and has the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int1010-aprepitant.htm">Aprepitant</a></td><td><p><span>metabolism of </span><span>methylprednisolone</span> <span>inhibited by</span> <span>aprepitant</span> <span>(reduce dose of <span>methylprednisolone</span>)</span></p></td><td></td></tr><tr><td><a href="bnf_int499-ciclosporin.htm">Ciclosporin</a></td><td class="cAI"><p><span>high-dose </span><span>methylprednisolone</span> <span>increases plasma concentration of</span> <span>ciclosporin</span> <span>(risk of convulsions)</span></p></td><td></td></tr><tr><td><a href="bnf_int168-clarithromycin.htm">Clarithromycin</a></td><td><p><span>plasma concentration of </span><span>methylprednisolone</span> <span>possibly increased by</span> <span>clarithromycin</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int468-diltiazem.htm">Diltiazem</a></td><td><p><span>plasma concentration of </span><span>methylprednisolone</span> <span>increased by</span> <span>diltiazem</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int169-erythromycin.htm">Erythromycin</a></td><td><p><span>metabolism of </span><span>methylprednisolone</span> <span>inhibited by</span> <span>erythromycin</span> <span></span></p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not apply to small amounts of erythromycin used topically</p></div></td></tr><tr><td><a href="bnf_int302-itraconazole.htm">Itraconazole</a></td><td><p><span>metabolism of </span><span>methylprednisolone</span> <span>possibly inhibited by</span> <span>itraconazole</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int298-ketoconazole.htm">Ketoconazole</a></td><td><p><span>metabolism of </span><span>methylprednisolone</span> <span>inhibited by</span> <span>ketoconazole</span> <span></span></p></td><td></td></tr></tbody></table><p><strong>Prednisolone</strong> belongs to <strong>Corticosteroids</strong> and has the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int499-ciclosporin.htm">Ciclosporin</a></td><td><p><span>plasma concentration of </span><span>prednisolone</span> <span>increased by</span> <span>ciclosporin</span> <span></span></p></td><td></td></tr><tr><td><a href="bnf_int400-ritonavir.htm">Ritonavir</a></td><td><p><span>plasma concentration of </span><span>prednisolone</span> <span>possibly increased by</span> <span>ritonavir</span> <span></span></p></td><td></td></tr></tbody></table><p><strong>Tetracosactide</strong> belongs to <strong>Corticosteroids</strong> but has no specific interaction information.</p><p><strong>Triamcinolone</strong> belongs to <strong>Corticosteroids</strong> but has no specific interaction information.</p></div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="bnf_int1193-prednisone.htm" title="Prednisone">Prednisone</a></li><li><a href="bnf_int1043-ciclesonide.htm" title="Ciclesonide">Ciclesonide</a></li><li><a href="bnf_int968-mometasone.htm" title="Mometasone">Mometasone</a></li><li><a href="bnf_int495-beclometasone.htm" title="Beclometasone">Beclometasone</a></li><li><a href="bnf_int487-betamethasone.htm" title="Betamethasone">Betamethasone</a></li><li><a href="bnf_int496-budesonide.htm" title="Budesonide">Budesonide</a></li><li><a href="bnf_int489-deflazacort.htm" title="Deflazacort">Deflazacort</a></li><li><a href="bnf_int490-dexamethasone.htm" title="Dexamethasone">Dexamethasone</a></li><li><a href="bnf_int485-fludrocortisone.htm" title="Fludrocortisone">Fludrocortisone</a></li><li><a href="bnf_int498-flunisolide.htm" title="Flunisolide">Flunisolide</a></li><li><a href="bnf_int497-fluticasone.htm" title="Fluticasone">Fluticasone</a></li><li><a href="bnf_int491-hydrocortisone.htm" title="Hydrocortisone">Hydrocortisone</a></li><li><a href="bnf_int492-methylprednisolone.htm" title="Methylprednisolone">Methylprednisolone</a></li><li><a href="bnf_int486-prednisolone.htm" title="Prednisolone">Prednisolone</a></li><li><a href="bnf_int894-tetracosactide.htm" title="Tetracosactide">Tetracosactide</a></li><li><a href="bnf_int493-triamcinolone.htm" title="Triamcinolone">Triamcinolone</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="bnf_int978-contraceptives-oral.htm">Previous: Contraceptives, oral</a> | <a class="top" href="bnf_int484-corticosteroids.htm#">Top</a> | <a accesskey="]" href="bnf_int1193-prednisone.htm">Next: Prednisone</a> ►</div></div></div></div><div id="pF"><div id="p2"><div id="pL"><div class="p4"><h2>Keep in touch</h2><ul><li><a href="http://www.pharmpress.com/?utm_source=medicinescomplete&amp;utm_medium=footer&amp;utm_campaign=medicinescomplete-referral">Pharmaceutical Press</a></li><li><a href="http://www.rpharms.com/">Royal Pharmaceutical Society</a></li><li><a href="http://www.pharmpress.com/mc-alerts.asp?utm_source=medicinescomplete&amp;utm_medium=footer&amp;utm_campaign=medicinescomplete-referral">Sign up for our eNewsletter</a></li><li><a href="http://twitter.com/#!/PharmPress/" class="p5"><img src="../../images/twitter.png" alt="Twitter logo" />Follow us on Twitter
              </a></li><li><a href="http://www.facebook.com/pages/Pharmaceutical-Press/296104187066918" class="p5"><img src="../../images/facebook.png" alt="Facebook logo" />Find us on Facebook
              </a></li></ul></div><div class="p4"><h2>Help and Support</h2><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a></li><li><a href="http://www.medicinescomplete.com/about/contact.htm">Contact Us</a></li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a></li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a></li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div><div class="p4"><h2>Provided for</h2><div id="cL"><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2013.  All rights reserved.</a></p><p><a href="http://www.medicinescomplete.com/mc/copyright.htm">MedicinesComplete © The Pharmaceutical Press 2013</a></p></div></div></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>